Search Within

Molly Anna Maloy

Formats
  1. Meeting Abstract (174)
  2. Journal Article (87)
  3. Research Letter (6)
  4. Correspondence (1)
  5. Review (1)
Groups
  1. DigITs Research Group (269)
  2. Department of Medicine (266)
  3. Hematologic Malignancies, Division of (263)
  4. Center for Hematologic Malignancies (262)
  5. Bone Marrow Transplant (261)
  6. Survivorship Research (208)

More Groups

People
  1. Sergio Giralt (225)
  2. Miguel-Angel Perales (196)
  3. Sean Devlin (162)
  4. Ann Jakubowski (133)
  5. Esperanza Papadopoulos (108)
  6. Craig Sauter (92)

More People

Years
  1. 2024 (1)
  2. 2023 (5)
  3. 2022 (11)
  4. 2021 (15)
  5. 2020 (42)
  6. 2019 (53)

More Years

Publications
  1. Biology of Blood and Marrow Transplantation (126)
  2. Blood (56)
  3. Bone Marrow Transplantation (31)
  4. Blood Advances (12)
  5. Leukemia and Lymphoma (6)
  6. Transplantation and Cellular Therapy (5)

More Publications

Publishers
  1. Elsevier Inc. (131)
  2. American Society of Hematology (68)
  3. Nature Publishing Group (34)
  4. Taylor & Francis Group (6)
  5. Wiley Blackwell (5)
  6. American Society of Clinical Oncology (4)

More Publishers

Results (269)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • CD34+ selected ex-vivo T-cell depleted grafts for allogeneic hematopoietic cell transplantation is associated with low incidence of acute and chronic graft-versus-host disease (GVHD) and high chronic-GVHD/relapse-free survival
    Meeting Abstract

    Barba, P.; Hilden, P.; Devlin, S.; Maloy, M.; Barker, J.; Castro-Malaspina, H.; Jakubowski, A.; Koehne, G.; Papadopoulos, E.; Sauter, C.; more...
    Bone Marrow Transplantation (2016)

    Fulltext@MSK | Save
  • Late toxicities in long-term survivors of adult allogeneic hematopoietic cell transplantation (allo-HCT) using ex-vivo CD34+ selection-based graft-versus-host disease (GVHD) prophylaxis
    Meeting Abstract

    Scordo, M.; Shah, G. L.; Devlin, S.; Maloy, M.; Kosuri, S.; Herrera, D. A.; Nieves, J.; Avecilla, S. T.; Meagher, R. C.; Gyurkocza, B.; more...
    Bone Marrow Transplantation (2016)

    Fulltext@MSK | Save
  • Sirolimus, tacrolimus and low-dose methotrexate as GVHD prophylaxis is safe and associated with promising results in patients receiving reduced-toxicity allogeneic hematopoietic cell transplantation
    Meeting Abstract

    Avila, A. M.; Barba, P.; Cho, C.; Devlin, S.; Ceberio, I.; Ponce, D.; Maloy, M.; Perales, M. A.
    Bone Marrow Transplantation (2016)

    Fulltext@MSK | Save
  • The hematopoietic cell transplantation comorbidity index (HCT-CI) predicts outcomes in patients with acute myeloid leukemia and myelodysplastic syndromes receiving CD34+ selected grafts for allogeneic hematopoietic cell transplantation
    Meeting Abstract

    Barba, P.; Ratan, R.; Ceberio, I.; Hilden, P.; Devlin, S.; Maloy, M.; Barker, J.; Castro-Malaspina, H.; Jakubowski, A.; Koehne, G.; more...
    Bone Marrow Transplantation (2016)

    Fulltext@MSK | Save
  • Fractionated infusion of hematopoietic progenitor cells (HPC) does not improve neutrophil recovery or survival in patients undergoing allogeneic
    Meeting Abstract

    Kosuri, S.; Gyurkocza, B.; Devlin, S. M.; Maloy, M.; Ciolino, C.; Borrill, T.; Jakubowski, A. A.; Papadopoulos, E.; Castro-Malaspina, H.; Koehne, G.; more...
    Biology of Blood and Marrow Transplantation (2016)

    Fulltext@MSK | Save
  • CD34+ selected ex-vivo T-cell depleted (TCD) grafts for allogeneic hematopoietic cell transplantation (Allo-HSCT) is associated with low incidence of acute and chronic graft-versus-host disease (GVHD) and high chronic-GVHD/relapse-free survival
    Meeting Abstract

    Barba, P.; Hilden, P.; Devlin, S. M.; Maloy, M.; Ciolino, C.; Dierov, D.; Herman, D.; Mosesso, K.; Nieves, J.; Barker, J. N.; more...
    Biology of Blood and Marrow Transplantation (2016)

    Fulltext@MSK | Save
  • Outcomes of diffuse large B-cell lymphoma (DLBCL) patients progressing after autologous hematopoietic stem cell transplant
    Meeting Abstract

    Gil-Cupello, M.; Shah, G. L.; Maloy, M. A.; Goldman, D. A.; Devlin, S. M.; Matasar, M. J.; Giralt, S. A.; Sauter, C. S.; Moskowitz, C. H.; Perales, M. A.
    Biology of Blood and Marrow Transplantation (2016)

    Fulltext@MSK | Save
  • Low dose unfractionated heparin (UFH) prophylaxis is a feasible strategy for the prevention of hepatic sinusoidal obstruction syndrome (SOS) after myeloablative adult allogeneic hematopoietic stem cell transplantation (HSCT)
    Meeting Abstract

    Bhatt, V.; Palazzo, M.; Kilroy, K.; Hilden, P.; Devlin, S. M.; Maloy, M.; Barker, J. N.; Castro-Malaspina, H.; Chung, D. J.; Dahi, P.; more...
    Biology of Blood and Marrow Transplantation (2016)

    Fulltext@MSK | Save
  • The hematopoietic cell transplantation comorbidity index (HCT-CI) predicts outcomes in patients with acute myeloid leukemia and myelodysplastic syndromes receiving CD34+ selected grafts for allogeneic hematopoietic cell transplantation
    Meeting Abstract

    Barba, P.; Ratan, R.; Ceberio, I.; Hilden, P.; Maloy, M.; Barker, J. N.; Castro-Malaspina, H.; Jakubowski, A. A.; Koehne, G.; Papadopoulos, E.; more...
    Biology of Blood and Marrow Transplantation (2016)

    Fulltext@MSK | Save
  • Systematic anti-mold prophylaxis results in very low incidence of invasive fungal infections in patients undergoing allogeneic hematopoietic cell transplantation
    Meeting Abstract

    Rosillo, C.; Barba, P.; Huang, Y. T.; Avila, A. M.; Montoro, J.; Maloy, M.; Papanicolaou, G. A.; Perales, M. A.
    Biology of Blood and Marrow Transplantation (2016)

    Fulltext@MSK | Save